Form 8-K - Current report:
SEC Accession No. 0001699031-25-000120
Filing Date
2025-05-16
Accepted
2025-05-16 16:05:53
Documents
16
Period of Report
2025-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gral-20250516.htm   iXBRL 8-K 34498
2 EX-10.1 a-8xkexxgrailx2025x05x12xf.htm EX-10.1 49423
6 footerimagea.jpg GRAPHIC 4995
7 image_header.jpg GRAPHIC 5858
  Complete submission text file 0001699031-25-000120.txt   239976

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gral-20250516.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gral-20250516_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gral-20250516_pre.xml EX-101.PRE 13045
19 EXTRACTED XBRL INSTANCE DOCUMENT gral-20250516_htm.xml XML 3386
Mailing Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025 (833) 694-2553
GRAIL, Inc. (Filer) CIK: 0001699031 (see all company filings)

EIN.: 863673636 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42045 | Film No.: 25959092
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)